|
MedChem 2011 - Emerging Targets and Treatments: Opportunities and Challenges for Drug Design |
25/11/2011 |
08:00 | Registration |
|
08:50 | Opening |
|
09:00 | Translocator Protein as a Promising Target for Novel Anxiolytics |
Prof. Federico DA SETTIMO (UNIVERSITÀ DI PISA, Pisa, Italy) |
09:50 | New Selective Androgen Receptor Modulators (SARM) for the Treatment of Cachexia |
Dr Pierre DEPREZ (GALAPAGOS, Romainville, France) |
10:40 | Coffee Break |
|
11:15 | Therapeutic Targeting of TLR Signalling |
Dr Brian KEOGH (OPSONA THERAPEUTICS LTD, Dublin 8, Ireland) |
12:05 | Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Discovery of an Orally Active TDO Inhibitor |
Prof. Raphaël FREDERICK (UCLOUVAIN, Bruxelles-Woluwé, Belgium) |
12:25 | Sandwich Lunch |
|
14:00 | Drug-to-Genome-to-Drug: Discovery and Optimisation of an Antimalarial Compound |
Prof. Benoit DEPREZ (UNIVERSITY OF LILLE 2, Lille, France) |
14:50 | Can Medicinal Chemistry Solve Target Related Issues? |
Dr Sandro BOLAND (AMAKEM NV, Diepenbeek, Belgium) |
15:10 | MASPIT, a Strategy for Small Molecule-Protein Interaction Mapping in Intact Human Cells |
Dr Sam LIEVENS (UGENT/VIB, Gent, Belgium) |
15:30 | Coffee Break and Poster Session |
|
16:05 | Targeting GSK-3 with ATP Non-Competitive Inhibitors: From the Bench to the Clinical Trials |
Prof. Ana MARTINEZ (INSTITUTO DE QUIMICA MEDICA-CSIC, Madrid, Spain) |
16:55 | New Targets for the Treatment of HIV |
Dr David PRYDE (PFIZER GLOBAL R&D, Sandwich, United Kingdom) |
17:45 | Closing Remarks |
|
<Previous page |